EPO and congestive heart failure: Anemia in patients with CHF is primarily caused by a deficiency of erythropoietin (EPO) or the decreased sensitivity of the spinal cord to EPO, and the application of EPO in the treatment of CHF complicated by anemia may have a marked curative effect (12–15).